Headlands Technologies »

Nektar Therapeutics shares owned by Headlands Technologies

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 41k 42.28
2025-09-30 $1.7M 30k 56.90
2025-06-30 $65k 2.5k 25.84

More positions owned by Headlands Technologies

Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Ishares Tr Iboxx Inv Cp Etf (LQD)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Booking Holdings (BKNG)
Electronic Arts (EA)
Bank of America Corporation (BAC)
Metropcs Communications (TMUS)
Exxon Mobil Corporation (XOM)
Roper Industries (ROP)
Nasdaq Omx (NDAQ)
Ross Stores (ROST)

View all positions for Headlands Technologies

Top funds holding Nektar Therapeutics

BVF
Susquehanna International
Vanguard Group
Two Seas Capital
BlackRock
Prosight Management
Citadel Advisors
Two Sigma Investments
Invesco
Millennium Management
Point72 Asset Management
Sofinnova Ventures
Emerald Advisers
22NW
Qube Research & Technologies

View all funds holding Nektar Therapeutics